D
Pfizer Inc. PFE
NYSE
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2023 10/01/2023 07/02/2023 04/02/2023 12/31/2022
Net Income -3.37B -- 2.33B 5.54B 4.99B
Total Depreciation and Amortization 1.67B -- 1.57B 1.47B 1.51B
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -1.51B -- -1.19B -293.00M -359.00M
Change in Net Operating Assets 8.45B -- -3.92B -5.51B 2.44B
Cash from Operations 5.24B -- -1.21B 1.21B 8.58B
Capital Expenditure -1.04B -- -914.00M -1.14B -1.00B
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -43.41B -- -25.00M -- -16.77B
Divestitures -- -- -- -- --
Other Investing Activities 33.45B -- -24.55B 4.45B 13.36B
Cash from Investing -11.00B -- -25.49B 3.32B -4.41B
Total Debt Issued 7.67B -- 30.63B 237.00M -866.00M
Total Debt Repaid 103.00M -- -1.00B -269.00M -1.91B
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -- -- -- -- 0.00
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -2.32B -- -2.32B -2.30B -2.25B
Other Financing Activities -18.00M -- -141.00M -436.00M 7.00M
Cash from Financing 5.44B -- 27.17B -2.77B -5.02B
Foreign Exchange rate Adjustments -1.00M -- -5.00M -2.00M -26.00M
Miscellaneous Cash Flow Adjustments -2.00M -- -1.00M -- -1.00M
Net Change in Cash -317.00M -- 475.00M 1.75B -870.00M
Weiss Ratings